Citigroup
LFST icon

Citigroup’s Lifestance Health LFST Stock Holding History

Citigroup’s Portfolio LFST Stock Details LFST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-41,500
Closed -$228K – 6284
2025
Q3 		$228K Buy
+41,500
New +$203K ﹤0.01% 3938

Other funds holding LFST

TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SP
Summit Partners Boston, Massachusetts $670M AUM 6.71% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SPIG
Silversmith Partners I GP Boston, Massachusetts $39.2M AUM
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Citigroup's LFST Position: Q1 2026 in Review

Citigroup increased its Lifestance Health (LFST) stake by 3,364% in Q1 2026, buying an estimated $4.03M and bringing the position to 595,735 shares worth $3.79M. The position accounts for ﹤0.01% of the portfolio, ranked #2175.

Citigroup first reported a position in LFST in Q2 2021 and has held it in 19 quarters since. 229 funds tracked by Wall St. Rank hold LFST as of Q1 2026.

  • Citigroup held 595,735 shares of Lifestance Health worth $3.79M as of Q1 2026.
  • Citigroup bought 578,538 Lifestance Health shares in Q1 2026, an estimated $4.03M.
  • Lifestance Health made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #2175 holding.
  • Citigroup first reported a position in Lifestance Health in Q2 2021 and has held it in 19 quarters since.
  • 229 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.